Latest Articles
SMC Issues Advice on 7 Medicines in Latest Meeting - NAVLIN DAILY
SMC Issues Advice on 7 Medicines in Latest Meeting NAVLIN DAILY
Published: Oct. 14, 2025, 12:08 p.m.
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Oct. 8, 2025, 7:30 p.m.
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com
Published: Oct. 8, 2025, 2:15 p.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Vulcan Post
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Vulcan Post
Published: Oct. 8, 2025, 7:33 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Malaysian Reserve
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Malaysian Reserve
Published: Oct. 8, 2025, 2:14 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Fidelity
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Fidelity
Published: Oct. 8, 2025, 1:35 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Manila Times
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Manila Times
Published: Oct. 8, 2025, 1:23 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - PR Newswire
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment PR Newswire
Published: Oct. 8, 2025, 1:08 a.m.
Aggressive Endometrial Cancer Linked to Metabolic Activity in Visceral Fat - Inside Precision Medicine
Aggressive Endometrial Cancer Linked to Metabolic Activity in Visceral Fat Inside Precision Medicine
Published: Oct. 4, 2025, 10:01 p.m.
Retraction Note: NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response - BMC Medicine
Retraction Note: NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response BMC Medicine
Published: Sept. 20, 2025, 4:22 a.m.
Link copied to clipboard!